Computational models of the glucoregulatory system constitute a powerful tool for preclinical evaluation and mechanistic insight into therapeutics. However, in the case of diabetes, there is a dearth ...

The company had filed draft papers for its IPO with Sebi in September 2024, and which was approved by the market regulator in ...